Evidence map›Paper›PMID 36273432›Full record

ArticleHuman mutation2022

SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing.

Raphaël Leman, Béatrice Parfait, Dominique Vidaud, Emmanuelle Girodon, Laurence Pacot, Gérald Le Gac, Chandran Ka, Claude Ferec, Yann Fichou, Céline Quesnelle and 26 more

Open access · hybridAbstract read
In one paragraph

Article in Human mutation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Molecular genetics and metabolism reports · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Predicting human mRNA isoform levels from site-specific splicing kineticsbioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Recurrent nonsense p.Trp3416* variant in theJournal of neuromuscular diseases · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

36 authors at 9 institutions in 3 countries.

Raphaël LemanLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.ORCID 0000-0003-1978-7133
Béatrice ParfaitService de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France.
Dominique VidaudService de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France.
Emmanuelle GirodonService de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France.ORCID 0000-0001-7913-4682
Laurence PacotService de Génétique et Biologie Moléculaires, APHP, HUPC, Hôpital Cochin, Paris, France.
Gérald Le GacInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Chandran KaInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Claude FerecInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Yann FichouInserm UMR1078, Genetics, Functional Genomics and Biotechnology, Université de Bretagne Occidentale, Brest, France.
Céline QuesnelleLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Camille AucouturierLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Etienne MullerLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Dominique VaurLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Laurent CasteraLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Flavie BoulouardLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Agathe RicouLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Hélène TubeufInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.ORCID 0000-0001-6671-1567
Omar SoukariehInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.
Pascaline GaildratInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.
Florence RiantLaboratoire de Génétique, AP-HP, GH Saint-Louis-Lariboisière-Fernand Widal, Paris, France.
Marine Guillaud-BatailleDépartement de Biopathologie, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Sandrine M CaputoDepartment of Genetics, Institut Curie, Paris Sciences Lettres Research University, Paris, France.ORCID 0000-0001-5338-9388
Virginie Caux-MoncoutierDepartment of Genetics, Institut Curie, Paris Sciences Lettres Research University, Paris, France.
Nadia Boutry-KryzaUnité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon, Lyon, France.
Françoise Bonnet-DorionDepartement de Biopathologie Unité de Génétique Constitutionnelle, Institut Bergonie-INSERM U1218, Bordeaux, France.
Ines SchultzLaboratoire d'Oncogénétique, Centre Paul Strauss, Strasbourg, France.
Maria RossingCentre for Genomic Medicine, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Olivier QuenezInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.ORCID 0000-0002-8273-8505
Louis GoldenbergInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.
Valentin HarterDepartment of Biostatistics, Baclesse Unicancer Center, Caen, France.
Michael T ParsonsDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.ORCID 0000-0003-3242-8477
Amanda B SpurdleDepartment of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.ORCID 0000-0003-1337-7897
Thierry FrébourgInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.
Alexandra MartinsInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.ORCID 0000-0003-4322-8497
Claude HoudayerInserm U1245, UNIROUEN, FHU-G4 génomique, Normandie Université, Rouen, France.
Sophie KriegerLaboratoire de Biologie et Génétique du Cancer, Centre François Baclesse, Caen, France.
Inserm · FRHôpital Cochin · FRCentre François Baclesse · FRQIMR Berghofer Medical Research Institute · AUUniversité Paris Sciences et Lettres · FRHôpital Fernand-Widal · FRHospices Civils de Lyon · FRUniversité Paris-Saclay · FRUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modeling splicing is essential for tackling the challenge of variant interpretation as each nucleotide variation can be pathogenic by affecting pre-mRNA splicing via disruption/creation of splicing motifs such as 5'/3' splice sites, branch sites, or splicing regulatory elements. Unfortunately, most in silico tools focus on a specific type of splicing motif, which is why we developed the Splicing Prediction Pipeline (SPiP) to perform, in one single bioinformatic analysis based on a machine learning approach, a comprehensive assessment of the variant effect on different splicing motifs. We gathered a curated set of 4616 variants scattered all along the sequence of 227 genes, with their corresponding splicing studies. The Bayesian analysis provided us with the number of control variants, that is, variants without impact on splicing, to mimic the deluge of variants from high-throughput sequencing data. Results show that SPiP can deal with the diversity of splicing alterations, with 83.13% sensitivity and 99% specificity to detect spliceogenic variants. Overall performance as measured by area under the receiving operator curve was 0.986, better than SpliceAI and SQUIRLS (0.965 and 0.766) for the same data set. SPiP lends itself to a unique suite for comprehensive prediction of spliceogenicity in the genomic medicine era. SPiP is available at: https://sourceforge.net/projects/splicing-prediction-pipeline/.

Indexed as

RNA Splice SitesRNA SplicingBayes TheoremExonsHumansIntronsMachine LearningRNA Splice Sitesmachine learningRNAsequence variantsSPiPsplicing predictions

Identifiers

PMID36273432
PMCPMC10946553
OpenAlexW4307106829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.